Willingness and Barriers to Undertaking Cardiopulmonary Resuscitation Reported by Medical Students after the SARS-CoV-2 Pandemic-Single-Center Study.

Willingness and Barriers to Undertaking Cardiopulmonary Resuscitation Reported by Medical Students after the SARS-CoV-2 Pandemic-Single-Center Study.

Publication date: Jan 13, 2024

Most of the studies in the field of willingness and barriers to resuscitation (CPR) were conducted before the SARS-CoV-2 pandemic. The aim of the study was to assess the number and types of barriers to CPR among medical students after the pandemic ended. This study was based on a survey. The data was collected from 12 April 2022 to 25 May 2022. A total of 509 complete questionnaires were obtained. The number of barriers depending on the time elapsed from the last CPR course did not differ significantly (Me = 4 [IQR 2-6] vs. Me = 5 [IQR 3-7]; p = 0. 054, respectively). The number of all barriers reported by respondents differed significantly and was higher in those reporting fear of coronavirus (Me = 4 [IQR 2-6] vs. Me = 7 [IQR 4-9]; p < 0. 001, respectively). A total of 12 out of all 23 barriers were significantly more frequent in this group of respondents. Barriers to CPR are still common among medical students, even despite a high rate of CPR training. The pandemic significantly affected both the number and frequency of barriers. The group of strangers and children, as potential cardiac arrest victims, deserve special attention. Efforts should be made to minimize the potentially modifiable barriers.

Open Access PDF

Concepts Keywords
April cardiopulmonary resuscitation
Arrest CPR
Cardiopulmonary education
Complete out-of-hospital cardiac arrest
Students resuscitation

Semantics

Type Source Name
disease VO time
disease VO frequency
disease MESH cardiac arrest
disease MESH Emergency
disease MESH out of hospital cardiac arrest
disease MESH Sudden cardiac arrest
disease IDO quality
drug DRUGBANK Coenzyme M
disease IDO history
disease VO population
disease VO vaccinated
disease IDO process
drug DRUGBANK Methionine
disease VO device
disease MESH Uncertainty
disease MESH panic
drug DRUGBANK Ethanol
disease IDO blood
disease MESH infection
disease VO effective
drug DRUGBANK Tacrine
drug DRUGBANK Efavirenz
drug DRUGBANK Guanosine
disease MESH COVID 19
drug DRUGBANK Cyclic Adenosine Monophosphate

Original Article

(Visited 1 times, 1 visits today)